Stay updated on LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.

Latest updates to the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.2 is displayed, and the previous Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe revision history updates to v3.5.0, replacing the previous v3.4.3 entry.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded Revision: v3.4.2; removed the former operating-status notice about government funding and the previous Revision: v3.4.1.SummaryDifference0.3%

- Check77 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, with guidance to check cc.nih.gov and opm.gov. The page revision tag changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check84 days agoChange DetectedThe page adds a 'Show glossary' option and updates footer metadata, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing 'No FEAR Act data' and the older 'Last Update Submitted that met QC Criteria' reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to LAG-3 in GBM: Alone & with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAG-3 in GBM: Alone & with Nivolumab Clinical Trial page.